argenx SE
- ARGX
- NASDAQ
- Biotechnology
- Autoimmune Disease Therapies
- Antibody Therapeutics
$819.14
Today −3.21%Quote Oct 16, 2026, 08:00 PM UTC
−17.74%over the last month
Max drawdown −19.4%From 1-month high −17.7%3 months −3.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$51.51B
Quote Oct 16
Next earnings
Mar 4
Expected, not confirmed
Analyst target
$1138.60
+39.0% from here
Floor
$760.94
7.1% below price
Where the price sits
36 analysts
Analyst range, low to high
$823.00$1400.00
- Price $819.14
- Resistance $830.43–$838.78
- Consensus $1138.60
The price is right under resistance. Analysts' average target sits about 39% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ARGXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
1,863